{"id":21379,"date":"2025-01-13T19:54:09","date_gmt":"2025-01-13T11:54:09","guid":{"rendered":"https:\/\/flcube.com\/?p=21379"},"modified":"2025-04-02T21:26:43","modified_gmt":"2025-04-02T13:26:43","slug":"eli-lilly-in-advanced-talks-to-acquire-scorpion-therapeutics-for-2-5-billion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=21379","title":{"rendered":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion"},"content":{"rendered":"\n

US-based Eli Lilly and Company (NYSE: LLY<\/a>) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly’s presence in the oncology sector.<\/p>\n\n\n\n

Deal Details and Timeline<\/strong>
According to insiders, the deal is expected to close before the J.P. Morgan Healthcare Conference commences this year, although it is not yet finalized. Under the proposed terms, Eli Lilly plans to make an upfront payment of USD 1 billion, with an additional maximum payment of USD 1.5 billion contingent upon reaching certain performance milestones. Both companies have remained silent on the reports, with no official response provided.<\/p>\n\n\n\n

Implications and Future Prospects<\/strong>
The potential acquisition of Scorpion Therapeutics by Eli Lilly highlights the ongoing consolidation in the biotech industry, particularly in the oncology space. If completed, the deal would provide Eli Lilly with access to Scorpion’s innovative pipeline and enhance its capabilities in developing novel cancer therapies. This move aligns with Eli Lilly’s strategic focus on expanding its oncology portfolio and strengthening its position in the competitive biopharmaceutical market.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm…<\/p>\n","protected":false},"author":1,"featured_media":21380,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[199,911,2958],"class_list":["post-21379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-eli-lilly","tag-nyse-lly","tag-scorpion-therapeutics"],"yoast_head":"\nEli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=21379\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion\" \/>\n<meta property=\"og:description\" content=\"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=21379\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-13T11:54:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-02T13:26:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion\",\"datePublished\":\"2025-01-13T11:54:09+00:00\",\"dateModified\":\"2025-04-02T13:26:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379\"},\"wordCount\":205,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1311.png\",\"keywords\":[\"Eli Lilly\",\"NYSE: LLY\",\"Scorpion Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21379#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=21379\",\"name\":\"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1311.png\",\"datePublished\":\"2025-01-13T11:54:09+00:00\",\"dateModified\":\"2025-04-02T13:26:43+00:00\",\"description\":\"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21379\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1311.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1311.png\",\"width\":1080,\"height\":720,\"caption\":\"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21379#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion - Insight, China's Pharmaceutical Industry","description":"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=21379","og_locale":"en_US","og_type":"article","og_title":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion","og_description":"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.","og_url":"https:\/\/flcube.com\/?p=21379","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-01-13T11:54:09+00:00","article_modified_time":"2025-04-02T13:26:43+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=21379#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=21379"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion","datePublished":"2025-01-13T11:54:09+00:00","dateModified":"2025-04-02T13:26:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=21379"},"wordCount":205,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=21379#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","keywords":["Eli Lilly","NYSE: LLY","Scorpion Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=21379#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=21379","url":"https:\/\/flcube.com\/?p=21379","name":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=21379#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=21379#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","datePublished":"2025-01-13T11:54:09+00:00","dateModified":"2025-04-02T13:26:43+00:00","description":"US-based Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks with compatriot firm Scorpion Therapeutics, with the aim of acquiring the oncology biotech for a potential USD 2.5 billion. This strategic move is expected to significantly expand Eli Lilly's presence in the oncology sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=21379#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=21379"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=21379#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","width":1080,"height":720,"caption":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=21379#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli Lilly in Advanced Talks to Acquire Scorpion Therapeutics for $2.5 Billion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1311.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21379"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21379\/revisions"}],"predecessor-version":[{"id":21381,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21379\/revisions\/21381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/21380"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}